We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Halts Promacta Trial Due to Thrombotic Events
GSK Halts Promacta Trial Due to Thrombotic Events
May 14, 2010
GlaxoSmithKline said it halted a trial of its low blood platelet treatment Promacta in patients with liver disease after six patients in the study (4 percent of the total group) experienced blood clots.